Oncology Research and Treatment

Papers
(The TQCC of Oncology Research and Treatment is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Follow-Up Time of Anal Cancer Screening among Women Living with HIV at High Risk of Developing Anal Cancer27
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 202326
uGI: Biomaker-Cut-Offs in der Immunonkologie22
Front & Back Matter18
PharmaNews10
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience9
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab9
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis8
Society Bulletins8
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study8
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study8
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease8
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem7
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer – What Tools Do We Have to Make the Right Decision?7
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial7
Career and Professional Development for Young Oncologists7
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center7
PharmaNews6
Society Bulletins5
PharmaNews5
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer5
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine5
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz5
DKK 2024: Acalabrutinib im Praxis-Check5
OnkoImmun 215
Front & Back Matter5
PharmaNews5
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology4
Vorwort des DGHO-Vorstands4
Society Bulletins4
Capivasertib/Fulvestrant bei ER+/HER2– MBC4
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany4
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients4
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial4
Epcoritamab: Indikationserweiterung für das FL4
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors4
Erratum4
PharmaNews4
PharmaNews4
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report4
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality3
Management of Advanced Penile Cancer3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%3
Psychological Stress in Breast Cancer Patients during the Course of a Pandemic Disease: Before and after the Availability of Vaccines3
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL3
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer3
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models3
Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie3
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 Investigation3
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi3
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen3
Society Bulletins3
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich2
Guidelines of Onkopedia: What Is New?2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20232
Erweiterte Therapieoptionen bei EGFRm NSCLC2
Front & Back Matter2
OnkoImmun 192
Oncology in Europe2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study2
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey2
Prelims2
Front & Back Matter2
Management of Patients Undergoing CAR-T Cell Therapy in Germany2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment2
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer2
Acknowledgement to Reviewers2
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie2
PharmaNews2
Society Bulletins2
Society Bulletins2
Perspectives for Cancer Care and Research in Central and Eastern Europe2
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy2
Ovarian Cancer and Its Association with Endometriosis: A Narrative Review1
Moving tumor-agnostic therapy to the big stage – translational and molecular oncology highlights from the ESMO Congress 20251
Society Bulletins1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20221
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies1
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma1
PharmaNews1
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer1
Front & Back Matter1
Contents Vol. 47, 20241
Society Bulletins1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast1
Impact of Epidural Anesthesia on the Outcome of Elderly Patients with Endometrial Cancer: Results of a Propensity Score-Matched Analysis1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres1
Society Bulletins1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC1
Onkologische Patient*innen individuell behandeln und begleiten1
Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–20181
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis1
Prognostic Significance of HER2 Positivity in Endometrium Cancer1
OnkoImmun 181
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines1
Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database1
Society Bulletins1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review1
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel1
Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment1
PharmaNews1
Prelims1
0.11856198310852